(¿Â¶óÀÎ) 2021 ´ëÇÑÁ¶Ç÷¸ð¼¼Æ÷À̽ÄÇÐȸ ±¹Á¦Çмú´ëȸ (ICBMT 2021 Viirtual) - 8¿ù 28ÀÏ (3ÀÏÂ÷) : 2021-08-28±³À°ÀÏÀÚ : 2021-08-28
±³À°Àå¼Ò : ¿Â¶óÀÎ
±³À°ÁÖÁ¦ :
(¿Â¶óÀÎ) 2021 ´ëÇÑÁ¶Ç÷¸ð¼¼Æ÷À̽ÄÇÐȸ ±¹Á¦Çмú´ëȸ (ICBMT 2021 Viirtual) - 8¿ù 28ÀÏ (3ÀÏÂ÷)ÁÖÃÖ±â°ü : ´ëÇÑÁ¶Ç÷¸ð¼¼Æ÷À̽ÄÇÐȸ
´ã´çÀÚ : À±ÁöÇö
¿¬¶ôó : 070-4895-6129
À̸ÞÀÏ :
bmt@kams.or.kr ±³À°Á¾·ù : ³»°ú, ¼Ò¾Æû¼Ò³â°ú, Áø´Ü°Ë»çÀÇÇаú
Âü¼®¿¹»óÀοø : 600¸í
Èñ¸ÁÆòÁ¡ : 3Á¡
Áö¿ª :
¼¿ïƯº°½Ã±³À°½Ã°£ : 3 ½Ã°£ 0ºÐ
¼¼ºÎ¼ö°·á : 20,000¿ø
ºñ°í
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 08-28 CA B 09:00~09:30 Autologous Stem Cell Transplantation for Aggressive B-cell Lymphomas in the Frontline Setting: Current Controversies and Advances Narendranath Epperla(The Ohio State University Comprehensive Cancer Center)
±³À°½Ã°£ 08-28 CA B 09:30~10:00 High Dose Therapy and Autologous Stem Cell Transplantation in Patients with Indolent Lymphoma Julie M. Vose(University of Nebraska Medical Center)
±³À°½Ã°£ 08-28 CA B 10:00~10:30 The Role of Allogeneic Stem Cell Transplantation for Relapsed and Refractory Lymphoma in the Era of CAR-T Cell Therapy Youngwoo Jeon(The Catholic University of Korea)
±³À°½Ã°£ 08-28 CA A 10:40~11:10 Prophylactic/preemptive DLI Real World Experience Xiao jun Huang(Peking University Institute of Hematology)
±³À°½Ã°£ 08-28 CA A 11:10~11:40 Therapeutic DLI in Relapsed/Refractory Hematologic Malignancy Bhagirathbhai Dholaria(Vanderbilt University Medical Center)
±³À°½Ã°£ 08-28 CA A 11:40~12:10 PTCY Based Haplo and DLI Hyoung Jin Kang(Seoul National University College of Medicine)